2,255
Participants
Start Date
June 14, 2017
Primary Completion Date
December 4, 2020
Study Completion Date
July 23, 2021
Truvada
A fixed dose of oral co-formulated tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) will be used as PrEP.
Kenya Medical Research Institute, Kisumu
Desmond Tutu HIV Foundation, Cape Town
Wits Reproductive Health and HIV Institute, Johannesburg
Collaborators (1)
Desmond Tutu HIV Foundation
OTHER
Wits Reproductive Health and HIV Institute
OTHER
Kenya Medical Research Institute
OTHER
United States Agency for International Development (USAID)
FED
RTI International
OTHER
Harvard Medical School (HMS and HSDM)
OTHER
University of Pittsburgh
OTHER
National Institute of Mental Health (NIMH)
NIH
University of Washington
OTHER